Eduard Parellada, MD, MSc, PhD: Long-Acting Injectable Risperidone in the Treatment of Schizophrenia in Special Patient Populations

Name: Eduard Parellada, MD, MSc, PhD: Long-Acting Injectable Risperidone in the Treatment of Schizophrenia in Special Patient Populations
SKU: 2766
Availability: InStock

$30.00

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Categories: Psychopharmacology Bulletin, VOL 40 No. 2 Articles Tags: eduard-parellada, ethnicityrace, health-disparities, illness-characteristics, ipolar-disorder, md, msc, phd

Description

Eduard Parellada, MD, MSc, PhD: Long-Acting Injectable Risperidone in the Treatment of Schizophrenia in Special Patient Populations

Description

Eduard Parellada, MD, MSc, PhD

DRUG DISPOSITION & PHARMACOKINETICS

Long-Acting Injectable Risperidone in the Treatment of Schizophrenia in Special Patient Populations

Eduard Parellada, MD, MSc, PhD

Eileen P. Ahearn, MD, PhD: Fear, Anxiety, and the Neuroimaging of PTSD

Gahan J. Pandina: Adjunctive Risperidone in the Treatment of Generalized Anxiety Disorder: A Double-Blind, Prospective, Placebo-Controlled, Randomized Trial

Trisha Suppes, MD, PhD: Awareness of Metabolic Concerns and Perceived Impact of Pharmacotherapy in Patients with Bipolar Disorder: A Survey of 500 US Psychiatrists

Thomas J. Raedler, MD: Lithium-Induced Nephropathies

Eduard Parellada, MD, MSc, PhD: Long-Acting Injectable Risperidone in the Treatment of Schizophrenia in Special Patient Populations

Description

Eduard Parellada, MD, MSc, PhD

DRUG DISPOSITION & PHARMACOKINETICS

Long-Acting Injectable Risperidone in the Treatment of Schizophrenia in Special Patient Populations

Eduard Parellada, MD, MSc, PhD

Related products

Eileen P. Ahearn, MD, PhD: Fear, Anxiety, and the Neuroimaging of PTSD

Gahan J. Pandina: Adjunctive Risperidone in the Treatment of Generalized Anxiety Disorder: A Double-Blind, Prospective, Placebo-Controlled, Randomized Trial

Trisha Suppes, MD, PhD: Awareness of Metabolic Concerns and Perceived Impact of Pharmacotherapy in Patients with Bipolar Disorder: A Survey of 500 US Psychiatrists

Thomas J. Raedler, MD: Lithium-Induced Nephropathies